• SPX
  • 6084.19
  • 0.82 %
  • 49.2798
  • DJI
  • 44148.56
  • -0.22 %
  • -99.2695
  • N225
  • 39849.14
  • 1.21 %
  • 476.9102
  • FTSE
  • 8311.59
  • 0.12 %
  • 9.97
  • IXIC
  • 20034.895
  • 1.77 %
  • 347.6523
Tyme Technologies, Inc. (TYME) Stock Price, News & Analysis

Tyme Technologies, Inc. (TYME) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.29
Day's range
$0.32
50-day range
$0.233
Day's range
$0.3635
  • Country: US
  • ISIN: US90238J1034
52 wk range
$0
Day's range
$0
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score N/A
  • Piotroski Score N/A
  • Grade N/A
  • Symbol (TYME)
  • Company Tyme Technologies, Inc.
  • Price $0.31
  • Changes Percentage (8.07%)
  • Change $0.02
  • Day Low $0.29
  • Day High $0.32
  • Year High $0.00

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. As of September 16, 2022, Tyme Technologies, Inc. operates as a subsidiary of Syros Pharmaceuticals, Inc.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/07/2022
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.14
  • Trailing P/E Ratio -2.2678832116788
  • Forward P/E Ratio -2.2678832116788
  • P/E Growth -2.2678832116788
  • Net Income $-21,668,267

Income Statement

Quarterly

Annual

Latest News of TYME

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Tyme Technologies, Inc. Frequently Asked Questions

  • What were the earnings of TYME in the last quarter?

    In the last quarter Tyme Technologies, Inc. earnings were on Friday, February, 11th. The Tyme Technologies, Inc. maker reported -$0.03 EPS for the quarter, beating analysts' consensus estimates of -$0.06 by $0.03.

  • What is the Tyme Technologies, Inc. stock price today?

    Today's price of Tyme Technologies, Inc. is $0.31 — it has increased by +8.07% in the past 24 hours. Watch Tyme Technologies, Inc. stock price performance more closely on the chart.

  • Does Tyme Technologies, Inc. release reports?

    Yes, you can track Tyme Technologies, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Tyme Technologies, Inc. stock forecast?

    Watch the Tyme Technologies, Inc. chart and read a more detailed Tyme Technologies, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Tyme Technologies, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Tyme Technologies, Inc. stock ticker.

  • How to buy Tyme Technologies, Inc. stocks?

    Like other stocks, TYME shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Tyme Technologies, Inc.'s EBITDA?

    Tyme Technologies, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Tyme Technologies, Inc.’s financial statements.

  • What is the Tyme Technologies, Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Tyme Technologies, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Tyme Technologies, Inc.'s financials relevant news, and technical analysis. Tyme Technologies, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Tyme Technologies, Inc. stock currently indicates a “sell” signal. For more insights, review Tyme Technologies, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In